Results 121 to 130 of about 34,166 (308)

Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy [PDF]

open access: bronze, 1992
E. Hommel   +7 more
openalex   +1 more source

Modulators of Diacylglycerol Kinase Activity: A Review of Advances and Challenges

open access: yesMedicinal Research Reviews, EarlyView.
ABSTRACT Catalyzing the conversion of diacylglycerol (DAG) in phosphatidic acid (PA), diacylglycerol kinases (DGKs) play a pivotal role in all the physiological processes modulated by these two bioactive lipids, such as lipid metabolism and immune regulation.
Luisa Racca   +2 more
wiley   +1 more source

Nutrition In Diabetic Nephropathy

open access: yesJournal of Education, Health and Sport, 2018
Salwa Agata. Nutrition in diabetic nephropathy. Journal of Education, Health and Sport. 2018;8(3):200-207. eISNN 2391-8306. DOI http://dx.doi.org/10.5281/zenodo.1191319 http://ojs.ukw.edu.pl/index.php/johs/article/view/5343 https://pbn.nauka.gov.pl/sedno-webapp/works/859050 The journal has had 7 points in Ministry of Science and ...
openaire   +3 more sources

Global Leadership Initiative on Malnutrition as a predictor of mortality and prolonged hospitalization in emergency department patients: A prospective cohort study

open access: yesNutrition in Clinical Practice, EarlyView.
Abstract Background Early diagnosis of malnutrition is essential for rapid decision‐making regarding nutrition care to improve patient outcomes. We aimed to evaluate the prevalence of malnutrition using the Global Leadership Initiative on Malnutrition (GLIM) criteria and to assess the association of GLIM with 1‐year mortality and length of hospital ...
Renata Wolf   +4 more
wiley   +1 more source

Understanding the Increasing Prevalence of Obesity in Patients With Type 1 Diabetes: Strategies for Improving Clinical Care

open access: yesObesity, EarlyView.
ABSTRACT The presence of excess weight is no longer a distinguishing feature between patients with type 1 diabetes (T1D) and those with type 2 diabetes (T2D). Obesity treatment in patients with T2D improves glycemic control and reduces or even eliminates medication burden.
Kathleen R. Ruddiman   +2 more
wiley   +1 more source

Increased blood pressure and erythrocyte sodium/lithium countertransport activity are not inherited in diabetic nephropathy [PDF]

open access: bronze, 1990
Jan Skov Jensen   +8 more
openalex   +1 more source

Type 2 Diabetes Mellitus and Hearing Loss: A Prisma Systematic Review and Meta‐Analysis

open access: yesOtolaryngology–Head and Neck Surgery, EarlyView.
Abstract Objective To conduct a systematic review and meta‐analysis to assess the association between type 2 diabetes and hearing loss. Data Sources Search conducted in PubMed and Scopus databases for articles published between January 2019 and April 2024.
Miguel Caballero‐Borrego   +1 more
wiley   +1 more source

Glomerular function in advanced human diabetic nephropathy

open access: bronze, 1982
Jan A. Winetz   +4 more
openalex   +1 more source

Characteristics of Hearing Loss in Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis

open access: yesOtolaryngology–Head and Neck Surgery, EarlyView.
Abstract Methods A systematic review of CINAHL, Cochrane Library, PubMed, and SCOPUS databases was conducted according to PRISMA guidelines to identify studies evaluating T2DM and hearing loss. Primary outcome measures included continuous measures (mean), proportions (%), proportional difference (∆), and relative risks (RR) with 95% confidence ...
Cory Hyun‐su Kim   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy